These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 562369)

  • 1. Experimental and epidemiological estimation of seasonal and climato-geographical features of non-specific resistance of the organism to influenza.
    Shadrin AS; Marinich IG; Taros LY
    J Hyg Epidemiol Microbiol Immunol; 1977; 21(2):155-61. PubMed ID: 562369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination activity of live influenza vaccine in different seasons of the year.
    Zykov MP; Sosunov AV
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(4):453-9. PubMed ID: 3429857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary results of oral influenza vaccination with live attenuated viruses.
    DeBarbieri A; Crovari P; Cuneo-Crovari P; Badolati G; Giacometti G
    Dev Biol Stand; 1976; 33():213-9. PubMed ID: 782972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An electroaerosol device for group vaccination against influenza.
    Grinshpun L; Priimägi L; Subi K; Reinet J; Visnapuu L
    Z Erkr Atmungsorgane; 1978 Mar; 150(3):237-8. PubMed ID: 695738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neutralizing and inhibiting activity of hemagglutination of serum antibodies after natural infection and after vaccination with influenza virus A/USSR/90/77 (H1N1) strain].
    Profeta ML; Nardi G
    Boll Ist Sieroter Milan; 1983 May; 62(2):130-6. PubMed ID: 6626319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of an inhibitor-resistant live attenuated influenza vaccine in normal and asthmatic adults.
    Warshauer DM; Minor TE; Inhorn SL; Reed CE; Dick EC
    Dev Biol Stand; 1976; 33():184-90. PubMed ID: 782967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of cross-immune reactivity against influenza H5N1 from seasonal influenza vaccine in humans.
    Tang JW; Ngai KL; Chan PK
    J Med Virol; 2008 Nov; 80(11):1992-6. PubMed ID: 18814271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New vaccine approaches for seasonal and pandemic influenza.
    Palache B
    Vaccine; 2008 Nov; 26(49):6232-6. PubMed ID: 18674583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Seroconversion after vaccine with trivalent influenza vaccine during the epidemic season 1990/1 in Poland].
    Brydak L; Rudnicka H; Gut W; Magdzik W; Kańtoch M
    Przegl Epidemiol; 1992; 46(3):221-9. PubMed ID: 1296247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seasonal influenza activity in Hong Kong and its association with meteorological variations.
    Chan PK; Mok HY; Lee TC; Chu IM; Lam WY; Sung JJ
    J Med Virol; 2009 Oct; 81(10):1797-806. PubMed ID: 19697414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 May; 58(19):521-4. PubMed ID: 19478718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002-2005 influenza periods.
    Vila-Córcoles A; Rodriguez T; de Diego C; Ochoa O; Valdivieso A; Salsench E; Ansa X; Badía W; Saún N;
    Vaccine; 2007 Sep; 25(37-38):6699-707. PubMed ID: 17698263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune response to influenza vaccines.
    Ghendon Y
    Acta Virol; 1990 May; 34(3):295-304. PubMed ID: 1980401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine.
    Greenbaum E; Engelhard D; Levy R; Schlezinger M; Morag A; Zakay-Rones Z
    Vaccine; 2004 Jun; 22(20):2566-77. PubMed ID: 15193382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness.
    Hurwitz ES; Haber M; Chang A; Shope T; Teo ST; Giesick JS; Ginsberg MM; Cox NJ
    J Infect Dis; 2000 Oct; 182(4):1218-21. PubMed ID: 10979921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine.
    Greenbaum E; Furst A; Kiderman A; Stewart B; Levy R; Schlesinger M; Morag A; Zakay-Rones Z
    J Med Virol; 2001 Sep; 65(1):178-84. PubMed ID: 11505461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of dot blot method for the estimation of IgG antibodies among persons vaccinated against influenza].
    Siennicka J; Brydak L
    Przegl Epidemiol; 1996; 50(4):407-12. PubMed ID: 9132798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural challenge of subjects vaccinated with WRL 105 strain live influenza vaccine in a residential community.
    Morris CA; Freestone DS; Stealey VM
    Dev Biol Stand; 1976; 33():197-201. PubMed ID: 782969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.